← SynDRA
PELABRESIB
SynDRA canonical compound SYN0039852 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | BRD4 |
|---|
| Mechanism of action | bromodomain inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- BRD2 INHIBITOR
- Bromodomain and extra-terminal motif (BET) inhibitor
- BET bromodomain inhibitor
- BRDT INHIBITOR
- BRD3 INHIBITOR
ATC classes
- L01X · OTHER ANTINEOPLASTIC AGENTS
Cross-references
Synonyms
- CPI-0610
- CPI-0610 ANHYDROUS
- PELABRESIB ANHYDROUS
- PELABRESIB MONOHYDRATE
- CPI-232
- CPI-267232
- CPI0610
- PELABRESIB (CPI-0610)
- CPI 0610
- CPI-0610 anhydrous
- Pelabresib Anhydrous
- U4017GUQ06
- RefChem:928711
- BET Inhibitor CPI-0610
- DTXCID401507229
- Pelabresib (CPI-0610)
- C20H16ClN3O2
- PELABRESIB [INN]
- UNII-U4017GUQ06
- GTPL9120
- orb1089389
- SCHEMBL15926539
- SCHEMBL29382955
- GLXC-10214
- EX-A1612
- BDBM50510872
- MFCD28144505
- NSC784856
- s7853
- AKOS030526467
- CS-5592
- NSC-784856
- compound 10 [PMID: 26815195]
- NCGC00483135-01
- AS-73876
- DA-72382
- HY-12863
- BRD-K19871656-001-01-3
Look up PELABRESIB in the interactive SynDRA portal →